178 related articles for article (PubMed ID: 2652574)
1. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
Hricik DE; Zarconi J; Schulak JA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
[No Abstract] [Full Text] [Related]
2. Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients.
McDiarmid SV; Millis M; Terashita G; Ament ME; Busuttil R; Terasaki P
Transplant Proc; 1990 Aug; 22(4):1774-6. PubMed ID: 2117806
[No Abstract] [Full Text] [Related]
3. Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.
Häyry P; von Willebrand E; Ahonen J; Eklund B; Salmela K; Höckerstedt K; Pettersson E; Koskimies S
Transplant Proc; 1987 Feb; 19(1 Pt 2):1650-1. PubMed ID: 3079031
[No Abstract] [Full Text] [Related]
4. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
Blümke M; Kirste G; Wanner U; Wilms H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
[No Abstract] [Full Text] [Related]
5. Immunohistology of liver allografts in recipients managed with prophylactic OKT3.
Rohrer RJ; Jenkins RL; Khettry U; Pinson CW; Gallik-Karlson C; Monaco AP
Transplant Proc; 1989 Feb; 21(1 Pt 2):2249-50. PubMed ID: 2652729
[No Abstract] [Full Text] [Related]
6. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
Chapman JR; Morris PJ
Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
[No Abstract] [Full Text] [Related]
7. Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation.
De Pauw L; Abramowicz D; Goldman M; Vereerstraeten P; Kinnaert P; Toussaint C
Transplant Proc; 1990 Aug; 22(4):1759-60. PubMed ID: 2117800
[No Abstract] [Full Text] [Related]
8. Does the addition of azathioprine (Aza) to CyA monotherapy after a first rejection prevent a second rejection episode in kidney transplant patients?
Hourmant M; Taupin JL; Leymerigie F; Cantarovich D; Soulillou JP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1589-90. PubMed ID: 2652517
[No Abstract] [Full Text] [Related]
9. Treatment with OKT3 and cyclosporine for acute allograft rejection.
Schulak JA; Mayes JT; Hricik DE
Transplant Proc; 1991 Aug; 23(4):2119-22. PubMed ID: 1908150
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
[No Abstract] [Full Text] [Related]
11. Low-dose cyclosporine or azathioprine one year after renal transplantation.
Forwell MA; Bradley JA; Briggs JD; Brown MW; Junor BJ; Macpherson SG; Watson MA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1858-9. PubMed ID: 3079052
[No Abstract] [Full Text] [Related]
12. Steroid withdrawal in cyclosporine-treated living related donor renal transplant recipients.
Kupin W; Venkat KK; Oh HK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1623-4. PubMed ID: 2652528
[No Abstract] [Full Text] [Related]
13. Renal transplantation in children using cyclosporin A and azathioprine.
Clark AG; Rigden SP; Welsh KI; Bewick M; Koffman G; Haycock GB; Chantler C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1685-6. PubMed ID: 2652552
[No Abstract] [Full Text] [Related]
14. Cardiac transplantation in the sixth decade of life.
Szentpetery S; Thames M; Hanrahan J; Morris J; Lower RR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2492-4. PubMed ID: 3079089
[No Abstract] [Full Text] [Related]
15. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
Cortesini R; Berloco P; Famulari A; Trovati A; Iappelli M; Renna Molajoni E; Bachetoni A; Pretagostini R; Marinucci G; Capua A
Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
[No Abstract] [Full Text] [Related]
16. Histologic response to OKT3 therapy for hepatic allograft rejection.
Rohrer RJ; Jenkins RL; Khettry U; Benotti PN; Dodson TF; Karlson CG; Georgi BA; Monaco AP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2459-61. PubMed ID: 3079086
[No Abstract] [Full Text] [Related]
17. Pilot study on induction treatment with high-dose OKT3: preliminary observations in kidney transplantation.
Welter HF; Illner WD; Schleibner S; Abendroth D; Hancke E; Groh J; Land W
Transplant Proc; 1990 Oct; 22(5):2272. PubMed ID: 2120813
[No Abstract] [Full Text] [Related]
18. The incidence and quantity of antiidiotypic antibody formation after OKT3 monoclonal therapy in heart-transplant recipients.
Hesse CJ; Heyse P; Stolk BJ; Balk AH; Jutte NH; Mochtar B; Weimar W
Transplant Proc; 1990 Aug; 22(4):1772-3. PubMed ID: 2117805
[No Abstract] [Full Text] [Related]
19. A controlled trial of azathioprine in combination with cyclosporine in cadaveric renal transplantation.
Griffin PJ; Ferguson CJ; Ross WB; Salaman JR
Transplant Proc; 1990 Aug; 22(4):1369. PubMed ID: 2202112
[No Abstract] [Full Text] [Related]
20. Preservation of renal function using OKT3 in liver transplant patients.
Millis JM; Baquerizo A; Saleh S; Danovitch GM; Busuttil RW
Transplant Proc; 1989 Jun; 21(3):3551-2. PubMed ID: 2662524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
